Primary graft dysfunction after heart transplantation: Outcomes and resource utilization.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 15 10 2019
medline: 6 6 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

A unified definition of primary graft dysfunction (PGD) after heart transplantation was adopted in 2014, with moderate and severe PGD defined as a need for mechanical circulatory support. While risk factors for PGD are well identified, outcomes and resource utilization have not been well-studied. We examined the resource utilization and associated costs with PGD. All adult heart transplantations (2001-2016) from a statewide Society of Thoracic Surgery database were analyzed by dividing them into two groups-with PGD (requiring mechanical circulatory support) and without PGD. Of the 718 heart transplants, 110 (15.3%) patients developed PGD. Prevalence of PGD for the study duration ranged from 3.7% to 22.7% with no significant trend. The most frequently used mechanical circulatory support device was intra-aortic balloon pump (88%), followed by extracorporeal membrane oxygenation (17%), and catheter-based circulatory support devices (3%). There were no significant differences in demographics or preoperative variables between the two groups. Resource utilization such as total intensive care unit hours, ventilation hours, reoperation for bleeding, blood product transfusions, and length of stay were significantly higher in the PGD group. Postoperative complications were also higher in PGD group including operative mortality (31.8% vs 3.8%, P < .0001). The median cost of heart transplantation was significantly higher in the PGD group $229 482 ($126 044-$388 889) vs $101 788 ($72 638-$181 180) P < .0001. Primary graft dysfunction following heart transplantation developed in 15% of patients. Patients with PGD had significantly higher complications, resource utilization, and mortality. Preventive measures to address the development of PGD would reduce resource utilization and improve outcomes.

Sections du résumé

BACKGROUND BACKGROUND
A unified definition of primary graft dysfunction (PGD) after heart transplantation was adopted in 2014, with moderate and severe PGD defined as a need for mechanical circulatory support. While risk factors for PGD are well identified, outcomes and resource utilization have not been well-studied. We examined the resource utilization and associated costs with PGD.
METHODS METHODS
All adult heart transplantations (2001-2016) from a statewide Society of Thoracic Surgery database were analyzed by dividing them into two groups-with PGD (requiring mechanical circulatory support) and without PGD.
RESULTS RESULTS
Of the 718 heart transplants, 110 (15.3%) patients developed PGD. Prevalence of PGD for the study duration ranged from 3.7% to 22.7% with no significant trend. The most frequently used mechanical circulatory support device was intra-aortic balloon pump (88%), followed by extracorporeal membrane oxygenation (17%), and catheter-based circulatory support devices (3%). There were no significant differences in demographics or preoperative variables between the two groups. Resource utilization such as total intensive care unit hours, ventilation hours, reoperation for bleeding, blood product transfusions, and length of stay were significantly higher in the PGD group. Postoperative complications were also higher in PGD group including operative mortality (31.8% vs 3.8%, P < .0001). The median cost of heart transplantation was significantly higher in the PGD group $229 482 ($126 044-$388 889) vs $101 788 ($72 638-$181 180) P < .0001.
CONCLUSION CONCLUSIONS
Primary graft dysfunction following heart transplantation developed in 15% of patients. Patients with PGD had significantly higher complications, resource utilization, and mortality. Preventive measures to address the development of PGD would reduce resource utilization and improve outcomes.

Identifiants

pubmed: 31609510
doi: 10.1111/jocs.14274
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1519-1525

Subventions

Organisme : American Heart Association
Organisme : Center for Integrated Healthcare, U.S. Department of Veterans Affairs

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Mohammed Quader (M)

Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia.

Robert B Hawkins (RB)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, Virginia.

J Hunter Mehaffey (JH)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, Virginia.

Sula Mazimba (S)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, Virginia.

Gorav Ailawadi (G)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, Virginia.

Leora Yarboro (L)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, Virginia.

Jeffrey Rich (J)

Virginia Cardiac Services Quality Initiative, Virginia Beach, Virginia.

Alan Speir (A)

Inova Heart and Vascular Institute, Falls Church, Virginia.

Clifford Fonner (C)

Virginia Cardiac Services Quality Initiative, Virginia Beach, Virginia.

Luke Wolfe (L)

Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia.

Vigneshwar Kasirajan (V)

Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH